Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Gross Profit: 2019-2024

Historic Gross Profit for Kymera Therapeutics (KYMR) over the last 6 years, with Dec 2024 value amounting to $3.1 million.

  • Kymera Therapeutics' Gross Profit fell 26.12% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$238,000, marking a year-over-year decrease of 100.27%. This contributed to the annual value of $3.1 million for FY2024, which is 96.06% down from last year.
  • According to the latest figures from FY2024, Kymera Therapeutics' Gross Profit is $3.1 million, which was down 96.06% from $78.6 million recorded in FY2023.
  • Kymera Therapeutics' Gross Profit's 5-year high stood at $78.6 million during FY2023, with a 5-year trough of $3.1 million in FY2024.
  • In the last 3 years, Kymera Therapeutics' Gross Profit had a median value of $46.8 million in 2022 and averaged $42.8 million.
  • In the last 5 years, Kymera Therapeutics' Gross Profit skyrocketed by 1,059.99% in 2020 and then tumbled by 96.06% in 2024.
  • Kymera Therapeutics' Gross Profit (Yearly) stood at $34.0 million in 2020, then spiked by 114.00% to $72.8 million in 2021, then tumbled by 35.71% to $46.8 million in 2022, then skyrocketed by 67.84% to $78.6 million in 2023, then plummeted by 96.06% to $3.1 million in 2024.